Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery

Enrique P Gurfinkel1, Ricardo Perez de la Hoz, Viviana M Brito

  • 1ICyCC Fundación Favaloro, Av. Belgrano 1746 (1093) Capital Federal, Buenos Aires, Argentina. epgurfinkel@ffavaloro.org

Insights

For acute coronary syndrome patients with prior coronary artery bypass graft (CABG), invasive treatment showed similar hospital outcomes but fewer 6-month cardiovascular complications than non-invasive management. Invasive care led to more readmissions and procedures.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Coronary Syndromes

Background:

  • Evaluating management strategies for acute coronary syndrome (ACS) in patients with prior coronary artery bypass graft (CABG).
  • Assessing the impact of invasive versus non-invasive treatment on hospital and 6-month outcomes.

Purpose of the Study:

  • To compare hospital and 6-month outcomes in ACS patients with prior CABG based on invasive vs. non-invasive management.
  • To identify differences in mortality, myocardial infarction, and rehospitalization rates between treatment groups.

Main Methods:

  • Analysis of data from the Global Registry of Acute Coronary Events.
  • Inclusion of 3853 patients with prior CABG and ACS.
  • Comparison of outcomes between 3356 patients receiving non-invasive treatment and 497 undergoing invasive treatment (PCI within 48h).

Main Results:

  • Similar primary composite endpoints (death, MI, ischemia) during hospitalization (31% vs. 30%, P=0.53).
  • Comparable hospital mortality (3.4% vs. 3.2%) and non-fatal MI (3.4% vs. 5.1%).
  • Lower 6-month mortality (3.4% vs. 6.5%, P<0.02) and combined death/MI endpoint (P<0.01) in the invasive group; higher rates of unscheduled procedures in the invasive group.

Conclusions:

  • No significant difference in hospital outcomes between invasive and non-invasive management for ACS patients with prior CABG.
  • Invasive treatment associated with higher readmission rates and additional procedures but lower 6-month cardiovascular complications.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...